Hilton Head Capital Partners »

Dyne Therapeutics shares owned by Hilton Head Capital Partners

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Hilton Head Capital Partners from 13F filings

Historical chart of Hilton Head Capital Partners investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Hilton Head Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Hilton Head Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $76k 3.4k 22.21
2026-03-31 $26k 1.4k 18.13

More positions owned by Hilton Head Capital Partners

First Trust Etf Iv First Trust Enhanced Short First Tr Enh New (FTSM)
Shelton Equity Premium Income Etf Shelton Eqt Pre (SEPI)
Eli Lilly & Co. (LLY)
Lam Research Corporation Com New (LRCX)
Ft Vest Laddered Buffer Etf Ft Ladd Buff Etf (BUFR)
First Trust Nasdaq Rising Dividend Achievers Risng Divd Achiv (RDVY)
Schwab Us Dividend Equity Etf Us Dividend Eq (SCHD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Philip Morris International (PM)
Avantis International Equity Etf Intl Eqt Etf (AVDE)
Wal-Mart Stores (WMT)
Arm Holdings Sponsored Ads (ARM)

View all positions for Hilton Head Capital Partners

Top funds holding Dyne Therapeutics

Henderson Group
BlackRock
Jupiter Topco
FMR
Orbis Allan Gray
Atlas Venture Life Science Advisors
State Street Corporation
Vanguard Capital Management
TCG Crossover Management
Vanguard Portfolio Management
Fcpm Iii Services B.v.
Geode Capital Management
Vestal Point Capital
OrbiMed Advisors
Frazier Life Sciences Management

View all funds holding Dyne Therapeutics